Keystone Financial Group (Georgia)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Buy
916
+4
+0.4% +$1.37K 0.17% 43
2026
Q1
$321K Buy
912
+4
+0.4% +$1.43K 0.17% 44
2025
Q4
$297K Buy
908
+5
+0.6% +$1.59K 0.16% 49
2025
Q3
$255K Buy
903
+5
+0.6% +$1.45K 0.14% 55
2025
Q2
$265K Sell
898
-20
-2% -$5.67K 0.17% 50
2025
Q1
$248K Buy
918
+4
+0.4% +$1.18K 0.17% 52
2024
Q4
$238K Buy
+914
New +$271K 0.19% 60

Other funds holding AMGN

Keystone Financial Group (Georgia)'s AMGN Position: Q2 2026 in Review

Keystone Financial Group (Georgia) increased its Amgen (AMGN) stake by 0.44% in Q2 2026, buying an estimated $1.37K and bringing the position to 916 shares worth $332K. The position accounts for 0.17% of the portfolio, ranked #43.

Keystone Financial Group (Georgia) first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Keystone Financial Group (Georgia) held 916 shares of Amgen worth $332K as of Q2 2026.
  • Keystone Financial Group (Georgia) bought 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.17% of Keystone Financial Group (Georgia)'s portfolio in Q2 2026, its #43 holding.
  • Keystone Financial Group (Georgia) first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Keystone Financial Group (Georgia)'s 13F filing for Q2 2026, filed 21 Jul 2026.